Bezlotoxumab News
Bezlotoxumab currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Bezlotoxumab with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Zinplava is indicated for the prevention of recurrence of Clostridium difficile infection (CDI) in adults at high risk for recurrence of CDI.
- Evidence level: L5
- Predicted indications (20):
- acute female pelvic peritonitis (99.9%)
- embryonic cyst of fallopian tube (99.9%)
- tubal pregnancy (99.9%)
- salpingitis isthmica nodosa (99.9%)
- disease of uterine broad ligament (99.9%)
- lumbar spinal stenosis (99.9%)
- celiac trunk compression syndrome (99.9%)
- abdominal cystic lymphangioma (99.9%)
- abdominal ectopic pregnancy (99.9%)
- pelvic varices (99.9%)
- lymph node palisaded myofibroblastoma (99.9%)
- disease of retroperitoneum (99.9%)
- sacrum chordoma (99.9%)
- disease of peritoneum (99.9%)
- urethral disease (99.9%)
- pudendal neuralgia (99.8%)
- bronchial adenomas/carcinoids childhood (99.8%)
- non-seminomatous lesion (99.8%)
- ductal or ductular proliferation (99.8%)
- chondroid hamartoma (99.8%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.